Among the 108 osteosarcomas, 5% exhibited amplification of CDK4, but not MDM2, and 3% displayed amplification of both CDK4 and MDM2. In total, we included 33 samples from 25 osteosarcomas in the present study (Supplementary Table 1). This evidence concerns the gene MDM2 and osteosarcoma.